Position in CADL
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$295,259
-$44,876 QoQ
Shares Held
60,257
+0.1% QoQ
Ownership
0.082%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in CADL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Lido Advisors, LLC holds $41,372,144 across 33 Biotechnology names. CADL ranks #17 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
43,511 | $19,429,401 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
11,739 | $9,070,020 | |
| 3 | IDYA |
IDEAYA Biosciences, Inc.
|
55,463 | $1,848,027 | |
| 4 | TARS |
Tarsus Pharmaceuticals, Inc.
|
24,374 | $1,709,836 | |
| 5 | INCY |
Incyte Corp
|
13,037 | $1,227,042 | |
| 6 | IMNM |
Immunome Inc.
|
48,950 | $1,070,536 | |
| 7 | RPRX |
Royalty Pharma plc
|
19,254 | $923,614 | |
| 8 | CPRX |
Catalyst Pharmaceuticals, Inc.
|
26,841 | $664,583 |
All Filings in CADL
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $295,259 | 60,257 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $340,135 | 60,201 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $307,025 | 60,201 | Shares | Sole | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||